Plexiform neurofibroma is a hallmark finding in neurofibromatosis type 1, presenting as a complex mass involving multiple neural pathways. Radiographic evaluation plays a central role in diagnosis, surgical planning, and monitoring disease progression over time.
Imaging patterns vary by age, anatomical site, and degree of plexiform branching, making a structured review of key features essential for accurate interpretation. The following sections outline the core radiographic concepts, patterns, and clinical considerations.
| Imaging Modality | Typical Signal Characteristics | Key Strengths | Clinical Role |
|---|---|---|---|
| MRI T1-weighted | Hypointense to muscle | Anatomy detail, lesion margins | Baseline characterization |
| MRI T2-weighted | Hyperintense, often inhomogeneous | High soft-tissue contrast | Mapping cystic or myxoid change |
| MRI with contrast | Variable enhancement, serpiginous pattern | Vascularity, perineural spread | Surgical and treatment planning |
| CT | Isodense to muscle with bone detail | Bony remodeling, osseous involvement | Trunk and spine assessment |
| Ultrasound | Hypoechoic, heterogeneous | Dynamic imaging, superficial lesions | Pediatric screening, biopsy guidance |
MRI Patterns and Anatomic Distribution
On magnetic resonance imaging, plexiform neurofibroma typically demonstrates a target or fascicular pattern that reflects the underlying nerve fascicles. The lesion often intertwines along the course of a large peripheral nerve, producing a dumbbell or hourglass configuration when crossing an intervertebral foramen.
In the head and neck region, involvement of the trigeminal nerve or branches may mimic other skull base masses, while the brachial plexus is a common site in the upper extremity. Careful tracing of nerve roots on multiplanar reconstructions improves surgical navigation and reduces iatrogenic nerve injury risk.
Computed Tomography and Adjunctive Findings
Computed tomography is less sensitive than MRI for characterizing the soft tissue components of plexiform neurofibroma but provides essential information about osseous changes. Typical CT findings include cortical thinning, bony expansion, and scalloping along the affected nerve pathway.
Intraspinal extension through neural foramina, vertebral foraminal widening, and associated vertebral fusion anomalies such as hemivertebrae or butterfly vertebrae are frequently identified. In long-standing cases, dystrophic calcification within the tumor is uncommon but can occur, especially after prior biopsy or treatment.
Differential Diagnosis and Mimickers
Several entities can resemble plexiform neurofibroma on imaging, including schwannoma, perineural metastasis, malignant peripheral nerve sheath tumor, and other nerve sheath tumors in the setting of neurofibromatosis type 1. Age, clinical history, and associated features help distinguish these entities.
Schwannomas tend to be more well-circumscribed and often enhance homogenously, whereas plexiform neurofibroma typically demonstrates more diffuse, infiltrative growth with a conglomerate mass appearance. Malignant transformation, though rare, is an important consideration when there is rapid growth or new pain in a longstanding lesion.
Procedural and Clinical Correlation
Image-guided biopsy of plexiform neurofibroma can be challenging due to the heterogeneous architecture and risk of bleeding. When performed, careful planning using fusion techniques or tractography helps avoid vital neurovascular structures.
Clinical correlation with neurologic examination, symptom burden, and timeline of lesion evolution remains indispensable. Cross-sectional imaging should be interpreted in conjunction with detailed mapping of deficits to ensure that radiologic and functional findings align.
Key Points for Practice
- Use MRI with multiplanar reconstructions to track fascicular involvement and plan surgical approaches.
- Recognize characteristic bony remodeling on CT to support the diagnosis and guide orthopedic or spinal interventions.
- Integrate imaging findings with clinical and neurologic data to avoid misdiagnosis and inappropriate treatment.
- Maintain vigilance for interval changes that may indicate malignant transformation or treatment-related complications.
- Leverage advanced sequences such as T2-weighted fat saturation and diffusion-weighted imaging to improve lesion characterization.
FAQ
Reader questions
How can MRI distinguish plexiform neurofibroma from other nerve sheath tumors?
Plexiform neurofibroma typically shows a fascicular or target pattern on T2-weighted images, with serpiginous enhancement and involvement along multiple nerve fascicles, whereas schwannomas are more sharply circumscribed and enhance homogenously.
What bony changes are most specific for plexiform neurofibroma on CT?
CT commonly demonstrates bony expansion with thinned cortex, osseous scalloping, and sometimes vertebral foraminal widening, reflecting the slow, infiltrative growth along the nerve pathways.
Can contrast-enhanced CT replace MRI for evaluating plexiform neurofibroma?
Contrast-enhanced CT lacks the soft-tissue contrast of MRI and is generally insufficient for defining the full extent of plexiform lesions, especially in complex anatomic regions such as the skull base or spinal canal. Ultrasound is primarily useful for superficial lesions, guiding biopsy or marking targeted treatment areas, but it cannot assess deep neural structures or osseous involvement as reliably as MRI or CT.